BioCentury
ARTICLE | Financial News

MannKind soars on Afrezza vote

April 3, 2014 12:46 AM UTC

MannKind Corp. (NASDAQ:MNKD) jumped $2.97 (74%) to $6.99 on Wednesday after FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted on Tuesday that the company's Afrezza is safe and effectiv...